7 October 2024 false No description of principal activity Taxfiler 2024.6 16000535 business:PrivateLimitedCompanyLtd 2024-10-07 2025-10-31 16000535 2024-10-06 16000535 2024-10-07 2025-10-31 16000535 business:AuditExempt-NoAccountantsReport 2024-10-07 2025-10-31 16000535 business:FilletedAccounts 2024-10-07 2025-10-31 16000535 2025-10-31 16000535 business:Director1 2024-10-07 2025-10-31 16000535 business:RegisteredOffice 2024-10-07 2025-10-31 16000535 core:WithinOneYear 2025-10-31 16000535 core:ShareCapital core:PreviouslyStatedAmount 2025-10-31 16000535 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-10-31 16000535 core:PreviouslyStatedAmount 2025-10-31 16000535 business:SmallEntities 2024-10-07 2025-10-31 16000535 countries:EnglandWales 2024-10-07 2025-10-31 iso4217:GBP xbrli:pure
Company Registration No. 16000535 (England and Wales)
Synbio Lifescience Ltd. Unaudited accounts for the period from 7 October 2024 to 31 October 2025
Synbio Lifescience Ltd. Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Synbio Lifescience Ltd. Company Information for the period from 7 October 2024 to 31 October 2025
Director
Sadia Sultana
Company Number
16000535 (England and Wales)
Registered Office
Block 19 - Bench 3 Alderley Park, Congle Macclesfield SK10 4TF United Kingdom
- 3 -
Synbio Lifescience Ltd. Statement of financial position as at 31 October 2025
2025
Notes
£
Current assets
Cash at bank and in hand
1,010
Creditors: amounts falling due within one year
4
(11,745)
Net current liabilities
(10,735)
Net liabilities
(10,735)
Capital and reserves
Called up share capital
1,000
Profit and loss account
(11,735)
Shareholders' funds
(10,735)
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 15 May 2026 and were signed on its behalf by
Sadia Sultana Director Company Registration No. 16000535
- 4 -
Synbio Lifescience Ltd. Notes to the Accounts for the period from 7 October 2024 to 31 October 2025
1
Statutory information
Synbio Lifescience Ltd. is a private company, limited by shares, registered in England and Wales, registration number 16000535. The registered office is Block 19 - Bench 3 Alderley Park, Congle, Macclesfield, SK10 4TF, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2025
£
Trade creditors
1,622
Other creditors
1
Loans from directors
10,122
11,745
5
Average number of employees
During the period the average number of employees was 0.
- 5 -